ArticleEndocrine connections2025
Longitudinal trajectories of insulin resistance in women with polycystic ovary syndrome: a functional data analysis approach.
Article in Endocrine connections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Androgenetic alopecia in polycystic ovary syndrome: a cutaneous marker of systemic metabo-inflammatory and endocrine dysfunction.Endocrine connections · 2026Review
- Polycystic Ovary Syndrome and Cardiometabolic Health Across Generation: Insights from 25 Years of the Tehran Lipid and Glucose Study (TLGS).International journal of endocrinology and metabolism · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Insulin resistance (IR) plays a central role in the pathophysiology of polycystic ovary syndrome (PCOS), yet its long-term trajectory across different phenotypes and obesity statuses remains unclear. This study aimed to model longitudinal IR patterns in women with PCOS, those meeting an isolated PCOS criterion, and healthy controls. Methods: This population-based prospective study included 1,759 reproductive-aged women (18-49 years) from the Tehran Lipid and Glucose Study, categorized into PCOS (n = 287), isolated PCOS criterion (n = 536), and healthy control (n = 936) groups, stratified by BMI (<25 kg/m2, 25-29.99 kg/m2, and ≥30 kg/m2) and WC (<88 cm and ≥88 cm). Functional principal component analysis modeled HOMA-IR and fasting insulin level trajectories as sparse functional data. Results: Women with PCOS were younger (23.5 vs 25 and 28 years, P < 0.05) and had lower BMI than healthy controls (23.38 vs 24.46 kg/m2, P < 0.05), with no baseline differences in HOMA-IR. Both HOMA-IR and fasting insulin trajectories varied by obesity status. Women with PCOS and either obesity or central obesity showed a pronounced upward trend in IR over time, while those without general or central obesity exhibited more stable or improving patterns. In contrast, healthy and isolated criterion groups showed relatively stable or mildly increasing HOMA-IR and fasting insulin levels, with steeper increases in the presence of obesity. Conclusion: This study provides new insights into the diverse trajectories of IR among women with PCOS, those with an isolated PCOS criterion, and healthy controls. Progressive worsening of IR was observed in women with PCOS and obesity, while those with PCOS without obesity showed improvement. Healthy and isolated criterion groups exhibited more stable patterns.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.